Class information for:
Level 1: INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1843 2388 27.1 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1449 7299 INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTERVAL DEBULKING SURGERY Author keyword 59 84% 1% 32
2 SECONDARY CYTOREDUCTIVE SURGERY Author keyword 47 79% 1% 30
3 ADVANCED OVARIAN CANCER Author keyword 47 48% 3% 72
4 PRIMARY DEBULKING SURGERY Author keyword 45 94% 1% 16
5 CYTOREDUCTION Author keyword 43 38% 4% 90
6 OPTIMAL CYTOREDUCTION Author keyword 28 69% 1% 24
7 SECONDARY CYTOREDUCTION Author keyword 27 76% 1% 19
8 INTERVAL DEBULKING Author keyword 21 90% 0% 9
9 DIAPHRAGMATIC SURGERY Author keyword 17 100% 0% 8
10 DIAPHRAGM RESECTION Author keyword 15 88% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 INTERVAL DEBULKING SURGERY 59 84% 1% 32 Search INTERVAL+DEBULKING+SURGERY Search INTERVAL+DEBULKING+SURGERY
2 SECONDARY CYTOREDUCTIVE SURGERY 47 79% 1% 30 Search SECONDARY+CYTOREDUCTIVE+SURGERY Search SECONDARY+CYTOREDUCTIVE+SURGERY
3 ADVANCED OVARIAN CANCER 47 48% 3% 72 Search ADVANCED+OVARIAN+CANCER Search ADVANCED+OVARIAN+CANCER
4 PRIMARY DEBULKING SURGERY 45 94% 1% 16 Search PRIMARY+DEBULKING+SURGERY Search PRIMARY+DEBULKING+SURGERY
5 CYTOREDUCTION 43 38% 4% 90 Search CYTOREDUCTION Search CYTOREDUCTION
6 OPTIMAL CYTOREDUCTION 28 69% 1% 24 Search OPTIMAL+CYTOREDUCTION Search OPTIMAL+CYTOREDUCTION
7 SECONDARY CYTOREDUCTION 27 76% 1% 19 Search SECONDARY+CYTOREDUCTION Search SECONDARY+CYTOREDUCTION
8 INTERVAL DEBULKING 21 90% 0% 9 Search INTERVAL+DEBULKING Search INTERVAL+DEBULKING
9 DIAPHRAGMATIC SURGERY 17 100% 0% 8 Search DIAPHRAGMATIC+SURGERY Search DIAPHRAGMATIC+SURGERY
10 DIAPHRAGM RESECTION 15 88% 0% 7 Search DIAPHRAGM+RESECTION Search DIAPHRAGM+RESECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRIMARY CYTOREDUCTIVE SURGERY 269 89% 5% 124
2 DEBULKING SURGERY 142 67% 5% 129
3 SURGICAL CYTOREDUCTION 115 61% 5% 123
4 PRIMARY DEBULKING SURGERY 99 88% 2% 46
5 CYTOREDUCTIVE SURGERY 96 24% 14% 342
6 IV EPITHELIAL OVARIAN 73 88% 1% 35
7 SECONDARY CYTOREDUCTIVE SURGERY 72 58% 4% 84
8 2ND LOOK LAPAROTOMY 65 38% 6% 136
9 ADVANCED STAGE OVARIAN 54 80% 1% 33
10 DEBULKING 45 50% 3% 65

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis 2009 100 59 75%
Treatment of ovarian cancer in the older woman 2015 2 53 43%
Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction 2007 85 59 93%
Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining 'optimal' residual disease 2012 23 95 79%
Predicting Surgical Outcome in Patients With International Federation of Gynecology and Obstetrics Stage III or IV Ovarian Cancer Using Computed Tomography A Systematic Review of Prediction Models 2015 1 24 67%
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review 2009 54 75 81%
FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system? 2015 1 17 59%
Maximal cytoreductive effort in epithelial ovarian cancer surgery 2010 34 55 100%
Primary debulking surgery for advanced ovarian cancer: Are you a believer or a dissenter? 2014 5 94 72%
Role of surgery in ovarian carcinoma 2007 75 131 82%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KELLY GYNECOL ONCOL SERV 11 26% 1.5% 35
2 GYNECOL GYNECOL ONCOL 5 13% 1.5% 35
3 DAN SETLACEC GASTROINTESTINAL DIS LIVER TRA 4 75% 0.1% 3
4 DANISH CANC BIOBANK 3 60% 0.1% 3
5 EUROPEAN COMPETENCE OVARIAN CANC 2 23% 0.4% 9
6 CLIN DIAG INTERVENT 2 67% 0.1% 2
7 HEPATOBIL SERV 2 67% 0.1% 2
8 PET CYCLOTRON UNIT DIAGNOST INVEST 2 67% 0.1% 2
9 GYNAECOL ONCOL AMSTERDAM 2 33% 0.2% 4
10 BRANCH UTERINE CANC 1 38% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000240926 PLATINUM RESISTANT//RECURRENT OVARIAN CANCER//PEGYLATED LIPOSOMAL DOXORUBICIN
2 0.0000129291 INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL//INTRAPERITONEAL THERAPY
3 0.0000105502 UTERINE NEOPLASMS MR//PET DIAG//UTERINE NEOPLASMS STAGING
4 0.0000098900 BORDERLINE OVARIAN TUMOR//ENDOSALPINGIOSIS//BORDERLINE OVARIAN TUMORS
5 0.0000094460 ARID1A//CLEAR CELL CARCINOMA//OVARIAN CLEAR CELL CARCINOMA
6 0.0000080404 CA 125//HE4//HUMAN EPIDIDYMIS PROTEIN 4
7 0.0000069315 MILIARY BRAIN METASTASES//CARCINOMATOUS ENCEPHALITIS//EXTRAPERITONEAL METASTASES
8 0.0000069236 RISK OF MALIGNANCY INDEX//ADNEXAL MASSES//ADNEXAL MASS
9 0.0000059138 MALIGNANT BOWEL OBSTRUCTION//BOWEL OBSTRUCTION//VENTING GASTROSTOMY
10 0.0000056205 OREGOVOMAB//AFLIBERCEPT//GI PERFORATION